Ginkgo snaps up synbio rival Zymergen for $300m
Boston based Ginkgo Bioworks is acquiring California headquartered, Zymergen, for $300m, making it the company’s largest acquisition to date.
Archives for July 25, 2022
Another Sandoz biosimilar up for FDA inspection: this time one targeting multiple sclerosis
Sandoz said the US Food and Drug Administration (FDA) has accepted its biologics license application (BLA) for a natalizumab biosimilar, developed by Polpharma Biologics.
Bavarian Nordic’s smallpox vaccine approved for use against monkeypox in Europe
The European Commission has extended the marketing authorization for Bavarian Nordic’s smallpox vaccine, Imvanex, to include protection from monkeypox and disease caused by vaccinia virus.
Astellas to create $70m biotech campus in San Francisco
Astellas Pharma Inc. will build a biotechnology campus in South San Francisco: providing capabilities to develop cell and gene therapies.